[Effect of postoperative analgesia with flurbiprofen axetil and sufentanyl on metabolism of surgical patients with intestinal carcinoma].
OBJECTIVE
T To evaluate the effect of postoperative analgesia with flurbiprofen axetil combined with sufentanyl in modulating the metabolism of patients undergoing operations for intestinal carcinoma.


METHODS
Eighty patients undergoing operations for intestinal carcinoma were randomly assigned into two groups, in group A, the patients received postoperative analgesia with flurbiprofen axetil combined with sufentanyl, and in group B, only sufentanyl was given. Parenteral nutrition with restricted nitrogen resource was given in both groups. The Visual Analog Scale (VAS), body temperature and postoperative nitrogen balance were monitored postoperatively, and the concentrations of plasma cortisol, epinephrine, tumour necrosis factor-alpha(TNF-alpha) and interleukin-6 (IL-6) were measured perioperatively.


RESULTS
VAS at 24, 48, 72 h after operation were similar between the two groups (P>0.05). The changes in body temperature, nitrogen balance, TNF-alpha and IL-6 after operation were more obvious in group B than in group A, but significantly improved on postoperative day 3 (P<0.05) in the two groups. Flurbiprofen did not result in postoperative increase in cortisol and epinephrine.


CONCLUSIONS
Postoperative analgesia with flurbiprofen axetil and sufentanyl or with sufentanyl alone produces similar postoperative analgesic effect in patients undergoing operation for intestinal carcinoma, but the former protocol offers better interventional effect on protein catabolism and promotes nitrogen balance.
Feng
Xia
X
Department of Anesthesiology, First Affiliated Hospital, Department of Gastrointestinal Surgery, Guangzhou 510080, China. fengxiar@sina.com
Lin
Shi-Qing
SQ
Chen
Yu
Y
Wu
Xiao-Jian
XJ
D000328:Adult; D000368:Aged; D000698:Analgesia; D000779:Anesthetics, Local / Q000627:therapeutic use*; D002277:Carcinoma / Q000601:surgery*; D005260:Female; D005480:Flurbiprofen / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D015850:Interleukin-6 / Q000378:metabolism; D007414:Intestinal Neoplasms / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D010149:Postoperative Pain / Q000188:drug therapy* / Q000378:metabolism; D017409:Sufentanil / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D000779:Anesthetics, Local; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D005480:Flurbiprofen; D017409:Sufentanil; C504422:flurbiprofen axetil